ZNF330

ZNF330
Identifiers
AliasesZNF330, HSA6591, NOA36, zinc finger protein 330
External IDsMGI: 1353574 HomoloGene: 8714 GeneCards: ZNF330
Gene location (Human)
Chr.Chromosome 4 (human)[1]
Band4q31.21Start141,220,887 bp[1]
End141,234,697 bp[1]
RNA expression pattern


More reference expression data
Orthologs
SpeciesHumanMouse
Entrez

27309

30932

Ensembl

ENSG00000109445

ENSMUSG00000031711

UniProt

Q9Y3S2

Q922H9

RefSeq (mRNA)

NM_001292002
NM_014487

NM_145600

RefSeq (protein)

NP_001278931
NP_055302

NP_663575

Location (UCSC)Chr 4: 141.22 – 141.23 MbChr 8: 82.76 – 82.77 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Zinc finger protein 330 is a protein that in humans is encoded by the ZNF330 gene.[5][6][7]

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000109445 - Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000031711 - Ensembl, May 2017
  3. "Human PubMed Reference:".
  4. "Mouse PubMed Reference:".
  5. Bolivar J, Garcia-Cozar FJ, Astola A, Iglesias C, Pendon C, Valdivia MM (Aug 2001). "Genomic structure and chromosome location of the human gene encoding the zinc finger autoantigen ZNF330". Cytogenet Cell Genet. 93 (3–4): 234–8. doi:10.1159/000056989. PMID 11528117.
  6. Bolivar J, Diaz I, Iglesias C, Valdivia MM (Jan 2000). "Molecular cloning of a zinc finger autoantigen transiently associated with interphase nucleolus and mitotic centromeres and midbodies. Orthologous proteins with nine CXXC motifs highly conserved from nematodes to humans". J Biol Chem. 274 (51): 36456–64. doi:10.1074/jbc.274.51.36456. PMID 10593942.
  7. "Entrez Gene: ZNF330 zinc finger protein 330".

Further reading

  • Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
  • Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
  • Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
  • Lehner B, Sanderson CM (2004). "A Protein Interaction Framework for Human mRNA Degradation". Genome Res. 14 (7): 1315–23. doi:10.1101/gr.2122004. PMC 442147. PMID 15231747.
  • Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
  • Rush J, Moritz A, Lee KA, et al. (2005). "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells". Nat. Biotechnol. 23 (1): 94–101. doi:10.1038/nbt1046. PMID 15592455.

This article incorporates text from the United States National Library of Medicine, which is in the public domain.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.